
Bellerophon, which was spun out of biopharmaceutical company Ikaria last year, has filed for an initial public offering on Nasdaq.
The Hubert Burda-backed online handmade goods marketplace has raised more than $90m in venture capital over the last decade.
The Genomic Health-backed genetic testing company intends to raise $86m from an initial public offering on the New York Stock Exchange.
Spark Therapeutics, a spin-out of Children's Hospital of Philadelphia, is developing gene therapy treatments for a rare blinding disorder and haemophilia.
Mobile game developer Linekong previously $115m in three funding rounds from investors including IDG Capital Partners.
The molecular profiling company, backed by Novo, GlaxoSmithKline and Merck, is seeking to float on Nasdaq.
The Kraft-backed neuromuscular treatment developer is seeking $60m, which will be invested in research and marketing.
The Fosun Pharma-backed medical imaging company intends to raise the cash through an initial public offering and concurrent private placement.